Want to see CH:EVE full AI Analyst Report?
Top Page
Evolva Holding
(EVE)
Select Model
Select Model
Rating:47Neutral
Price Target:
CHF2.00
▼(-13.79% Downside)
Action:Reiterated
Date:08/18/26
The score is primarily held back by weak financial performance (zero revenue in 2024–2025 and persistent negative operating/free cash flow), with only partial support from a low-debt balance sheet and reduced recent cash burn. Technicals are moderately supportive due to price trading above key moving averages, but momentum indicators remain weak. Valuation is also a drag due to a negative P/E and no dividend yield data.
Positive Factors
Low financial leverage
No reported debt from 2023–2025 limits interest obligations and reduces balance-sheet pressure. This gives Evolva greater flexibility to manage losses, preserve available capital, and pursue strategic options without the added burden of significant leverage or refinancing exposure.
Negative Factors
Revenue base has disappeared
Revenue falling to zero in both 2024 and 2025 signals a severe loss of operating scale and commercial traction. Without recurring sales, Evolva lacks a demonstrated revenue engine to support investment, absorb fixed costs, or create durable earnings over the coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Low financial leverage
No reported debt from 2023–2025 limits interest obligations and reduces balance-sheet pressure. This gives Evolva greater flexibility to manage losses, preserve available capital, and pursue strategic options without the added burden of significant leverage or refinancing exposure.
Read all positive factors
Evolva Holding (EVE) vs. iShares MSCI Switzerland ETF (EWL)
Market Cap
CHF16.09M
Dividend YieldN/A
Average Volume (3M)21.29K
Price to Earnings (P/E)―
Beta (1Y)0.39
Revenue GrowthN/A
EPS Growth-39.83%
CountryCH
Employees49
SectorFinancial
Sector Strength70
IndustryShell Companies
Share Statistics
EPS (TTM)-0.09
Shares Outstanding7,230,626
10 Day Avg. Volume15,626
30 Day Avg. Volume21,289
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)0.98
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.5
Revenue Forecast (FY)CHF60.90M
Evolva Holding Business Overview & Revenue Model
Company Description
EvoNext Holdings SA is dedicated to the exploration, creation, and distribution of pioneering ingredients across the nutritional, health, and wellness domains. Founded in 2004, the company's inception is attributed to Alexandra Santana Sørensen, S...
Evolva Holding Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
58
Neutral
Cash Flow
21
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 9.44M | 15.54M | 9.88M |
| Gross Profit | 0.00 | 0.00 | -4.83M | -8.89M | -9.31M |
| EBITDA | -652.10K | 3.96M | -98.36M | -34.52M | -31.82M |
| Net Income | -652.70K | 1.04M | -105.23M | -43.37M | -41.27M |
Balance Sheet | |||||
| Total Assets | 6.76M | 7.54M | 9.83M | 131.01M | 156.17M |
| Cash, Cash Equivalents and Short-Term Investments | 5.61M | 6.75M | 5.84M | 5.14M | 11.00M |
| Total Debt | 0.00 | 0.00 | 0.00 | 15.06M | 10.84M |
| Total Liabilities | 812.70K | 945.30K | 4.28M | 24.77M | 24.40M |
| Stockholders Equity | 5.94M | 6.60M | 5.55M | 106.24M | 131.77M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | -2.44M | -9.72M | -21.13M | -33.57M |
| Operating Cash Flow | -1.14M | -2.44M | -9.25M | -18.88M | -29.79M |
| Investing Cash Flow | 0.00 | 3.52M | 15.95M | -1.76M | -4.64M |
| Financing Cash Flow | 0.00 | -163.10K | -5.97M | 14.77M | 25.72M |
Evolva Holding Technical Analysis
Positive
2.32
Price Trends
2.22
Negative
2.08
Positive
1.49
Positive
Market Momentum
>-0.01
Negative
52.12
Neutral
82.46
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:EVE, the sentiment is Positive. The current price of 2.32 is above the 20-day moving average (MA) of 2.15, above the 50-day MA of 2.22, and above the 200-day MA of 1.49, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 52.12 is Neutral, neither overbought nor oversold. The STOCH value of 82.46 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CH:EVE.
Evolva Holding Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | CHF6.03B | 39.15 | 10.27% | 1.16% | 4.51% | 11.05% | |
66 Neutral | CHF39.34B | -365.84 | ― | 0.89% | -10.77% | -114.77% | |
63 Neutral | CHF723.57M | 99.45 | 10.24% | ― | 40.91% | ― | |
51 Neutral | CHF134.45M | -2.43 | -67.67% | ― | -100.00% | 24.46% | |
47 Neutral | CHF16.09M | -17.28 | -16.47% | ― | ― | -39.83% |
* Financial Sector Average
CH:EVE
Evolva Holding
2.22
1.33
148.88%
CH:MOLN
Molecular Partners AG
3.31
0.33
10.89%
CH:LONN
Lonza Group Ltd
563.40
41.47
7.95%
CH:BANB
Bachem Holding AG
77.90
22.27
40.02%
CH:KURN
Kuros Biosciences
18.00
-11.00
-37.93%
CH:XLS
Xlife Sciences Ltd.
9.90
-9.90
-50.00%
Evolva Holding Corporate Events
EvoNext Posts Modest Loss as Talks Advance on Reverse Merger with Ascend Sport Technology
Sep 30, 2026
EvoNext Holdings SA reported liquidity of CHF 5.5 million and equity of CHF 5.3 million as of 30 June 2026, with a net loss of CHF 0.6 million driven mainly by one-off transaction and search-related costs. The company’s half-year figures hig...
EvoNext in advanced talks on reverse merger with AI sports tech firm Ascend
Aug 17, 2026
EvoNext Holdings SA has confirmed it is in advanced talks with Ascend Sport Technology AG over a reverse merger that would bring the profitable, AI-driven Swiss sports technology firm to the SIX Swiss Exchange. The contemplated deal envisages valu...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.